Suven Pharmaceuticals Limited (SUVENPHAR) — Net Asset Momentum
Suven Pharmaceuticals Limited (SUVENPHAR) recorded a net asset momentum of -10.2% as of March 2025, with net assets of Rs18.41 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Suven Pharmaceuticals Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Suven Pharmaceuticals Limited Net Asset Momentum (2019–2025)
This chart tracks Suven Pharmaceuticals Limited's year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is -10.2%, with net assets of Rs18.41 Billion INR as of March 2025. Read Suven Pharmaceuticals Limited balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Suven Pharmaceuticals Limited (2019–2025)
The table below shows the complete annual net asset history for Suven Pharmaceuticals Limited from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Suven Pharmaceuticals Limited market cap and net worth.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Rs18.41 Billion | Rs30.32 Billion | Rs11.91 Billion | ▼ -10.2% |
| 2024 | Rs20.51 Billion | Rs22.54 Billion | Rs2.03 Billion | ▲ +18.2% |
| 2023 | Rs17.35 Billion | Rs19.66 Billion | Rs2.31 Billion | ▲ +13.6% |
| 2022 | Rs15.27 Billion | Rs18.30 Billion | Rs3.02 Billion | ▲ +29.3% |
| 2021 | Rs11.81 Billion | Rs14.74 Billion | Rs2.94 Billion | ▲ +39.8% |
| 2020 | Rs8.45 Billion | Rs11.73 Billion | Rs3.28 Billion | ▲ +43.1% |
| 2019 | Rs5.90 Billion | Rs7.83 Billion | Rs1.93 Billion | — |